These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 10832825)

  • 41. Design of a multicenter, double-blind study to assess the effects of prophylactic diltiazem on early reinfarction after non-Q-wave acute myocardial infarction: diltiazem reinfarction study.
    Pratt CM; Gibson R; Boden W; Theroux P; Strauss H; Gheorghiade M; Capone R; Crawford M; Schlant R; Arensberg D
    Am J Cardiol; 1986 Nov; 58(10):906-10. PubMed ID: 3535473
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protective effects of calcium antagonists against ischaemia and reperfusion damage.
    Ferrari R; Visioli O
    Drugs; 1991; 42 Suppl 1():14-26; discussion 26-7. PubMed ID: 1718690
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of diltiazem on mortality and reinfarction after myocardial infarction.
    Multicenter Diltiazem Postinfarction Trial Research Group
    N Engl J Med; 1988 Aug; 319(7):385-92. PubMed ID: 2899840
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In-hospital and one-year outcomes of patients with high-risk acute myocardial infarction treated with thrombolysis or primary coronary angioplasty.
    Steffenino G; Santoro GM; Maras P; Mauri F; Ardissino D; Violini R; Chiarella F; Lucci D; Marini M; Baldasseroni S; Maggioni AP;
    Ital Heart J; 2004 Feb; 5(2):136-45. PubMed ID: 15086144
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.
    Fox K; Ford I; Steg PG; Tendera M; Ferrari R;
    Lancet; 2008 Sep; 372(9641):807-16. PubMed ID: 18757088
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
    Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
    Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial.
    Holman RR; Coleman RL; Chan JCN; Chiasson JL; Feng H; Ge J; Gerstein HC; Gray R; Huo Y; Lang Z; McMurray JJ; Rydén L; Schröder S; Sun Y; Theodorakis MJ; Tendera M; Tucker L; Tuomilehto J; Wei Y; Yang W; Wang D; Hu D; Pan C;
    Lancet Diabetes Endocrinol; 2017 Nov; 5(11):877-886. PubMed ID: 28917545
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcome with calcium channel antagonists after myocardial infarction: a community-based study.
    Leitch JW; McElduff P; Dobson A; Heller R
    J Am Coll Cardiol; 1998 Jan; 31(1):111-7. PubMed ID: 9426027
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial.
    Yusuf S; Mehta SR; Chrolavicius S; Afzal R; Pogue J; Granger CB; Budaj A; Peters RJ; Bassand JP; Wallentin L; Joyner C; Fox KA;
    JAMA; 2006 Apr; 295(13):1519-30. PubMed ID: 16537725
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial.
    Mahaffey KW; Puma JA; Barbagelata NA; DiCarli MF; Leesar MA; Browne KF; Eisenberg PR; Bolli R; Casas AC; Molina-Viamonte V; Orlandi C; Blevins R; Gibbons RJ; Califf RM; Granger CB
    J Am Coll Cardiol; 1999 Nov; 34(6):1711-20. PubMed ID: 10577561
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Predict value of clinical risk score, thrombolysis in myocardial infarction flow grade and combined clinical risk score plus TIMI flow on outcome evaluation of patients with acute coronary syndrome].
    Zhong B; Liu ZZ; Su L; Lan XB; Chen YQ; Ling ZY; Yin YH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jan; 36(1):30-5. PubMed ID: 19099923
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The treatment of ischemia in acute myocardial infarction].
    Kiowski W
    Schweiz Med Wochenschr; 1990 Oct; 120(42):1531-8. PubMed ID: 1978408
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of beta-blockers and calcium channel blockers in acute myocardial infarction.
    Held PH; Yusuf S
    Eur Heart J; 1993 Oct; 14 Suppl F():18-25. PubMed ID: 7903243
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of reviparin, a low-molecular-weight heparin, on mortality, reinfarction, and strokes in patients with acute myocardial infarction presenting with ST-segment elevation.
    Yusuf S; Mehta SR; Xie C; Ahmed RJ; Xavier D; Pais P; Zhu J; Liu L;
    JAMA; 2005 Jan; 293(4):427-35. PubMed ID: 15671427
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacologic management of ischemic heart disease with beta-blockers and calcium channel blockers.
    Pearle DL
    Am Heart J; 1990 Sep; 120(3):739-42; discussion 743-5. PubMed ID: 1975155
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term outcome after an early invasive versus selective invasive treatment strategy in patients with non-ST-elevation acute coronary syndrome and elevated cardiac troponin T (the ICTUS trial): a follow-up study.
    Hirsch A; Windhausen F; Tijssen JG; Verheugt FW; Cornel JH; de Winter RJ;
    Lancet; 2007 Mar; 369(9564):827-835. PubMed ID: 17350451
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reassessment of treadmill stress testing for risk stratification in patients with acute myocardial infarction treated by thrombolysis.
    Stevenson R; Umachandran V; Ranjadayalan K; Wilkinson P; Marchant B; Timmis AD
    Br Heart J; 1993 Nov; 70(5):415-20. PubMed ID: 8260271
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Invasive vs non-invasive treatment in acute coronary syndromes and prior bypass surgery.
    Gurfinkel EP; Perez de la Hoz R; Brito VM; Duronto E; Dabbous OH; Gore JM; Anderson FA;
    Int J Cardiol; 2007 Jun; 119(1):65-72. PubMed ID: 17045681
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High-grade infarct-related stenosis after successful thrombolysis: strong predictor of reocclusion, but not of clinical reinfarction.
    Kievit PC; Brouwer MA; Veen G; Karreman AJ; Verheugt FW
    Am Heart J; 2004 Nov; 148(5):826-33. PubMed ID: 15523313
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.